GlassScriptPhysician profile
Cherie L Booth
NPI 1003096819
$3,088.70
in general payments reported to CMS, 2019-2025
19 companies · $703 in 2025
The $703 reported for 2025 was more than what a typical Otology & Neurotology provider received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,079 · 2020: $292 · 2021: $225 · 2022: $250 · 2023: $287 · 2024: $252 · 2025: $703.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,241.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cochlear Americas | $1,043.78 | 2019-2025 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
| Medical Device Business Services, INC. | $710.01 | 2019 | |
| Acclarent, INC | $230.54 | 2019-2020 | |
| Integra Lifesciences Corporation | $218.17 | 2022-2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Stryker Corporation | $181.58 | 2019-2022 | |
| Genzyme Corporation | $143.24 | 2024-2025 | |
| Neurent Medical Limited | $119.41 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Optinose US, INC. | $116.31 | 2019-2023 | |
| Aerin Medical INC. | $50.38 | 2024-2025 | |
| Alk-Abello, INC | $42.00 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $38.44 | 2023 | Dupixent |
| Olympus America INC. | $37.91 | 2020-2024 | Rhino-Laryngo Videoscope |
| Intersect Ent, INC. | $33.34 | 2020 | |
| Arbor Pharmaceuticals, INC. | $26.44 | 2019 | |
| Kaleo, INC. | $23.22 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $23.02 | 2023 | Wavewriter Alpha Prime 16 |
| Si-Bone, INC. | $18.70 | 2020 | |
| Hikma Pharmaceuticals USA | $18.68 | 2023 | Ryaltris |
| Glaxosmithkline, LLC. | $13.53 | 2025 | Nucala |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cherie Booth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.